Show simple item record

dc.contributor.authorYiu, Daniel
dc.contributor.authorAguilar-Duran, Silvia
dc.contributor.authorEdwards, Charlotte
dc.contributor.authorChauhan, Dharmisha
dc.contributor.authorFurness, Andrew
dc.contributor.authorTurajlic, Samra
dc.contributor.authorLarkin, James
dc.contributor.authorFearfield, Louise
dc.contributor.authorHeelan, Kara
dc.date.accessioned2024-07-08T13:26:08Z
dc.date.available2024-07-08T13:26:08Z
dc.date.issued2024-05-16
dc.identifier.citationYiu D, Aguilar-Duran S, Edwards C, Chauhan D, Furness A, Turajlic S, Larkin J, Fearfield L, Heelan K. Increased incidence of co-trimoxazole induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors. Br J Dermatol. 2024 Aug 14;191(3):465-467. doi: 10.1093/bjd/ljae202.en_US
dc.identifier.eissn1365-2133
dc.identifier.doi10.1093/bjd/ljae202
dc.identifier.pmid38753744
dc.identifier.urihttp://hdl.handle.net/20.500.14200/5061
dc.description.abstractNo abstract availableen_US
dc.language.isoenen_US
dc.publisherBlackwell Scientific Publicationsen_US
dc.relation.urlhttp://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2133en_US
dc.subjectDermatologyen_US
dc.titleIncreased incidence of co-trimoxazole induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.en_US
dc.typeArticleen_US
dc.source.journaltitleBritish Journal of Dermatologyen_US
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.identifier.journalThe British journal of dermatology
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record